PBH — Prestige Consumer Healthcare Inc.
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1295947 ·
Last close
$46.67
Market Cap
$2.21B
52W High
$64.48
52W Low
$42.62
ADV30
775,991
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 281,617,000 | 146,299,000 | 75,492,000 | 53,928,000 | 3,494,313,000 | 63,868,000 | 1,606,797,000 |
| Dec 2025 | 283,444,000 | 157,369,000 | 82,491,000 | 46,696,000 | 3,494,743,000 | 62,373,000 | 1,665,292,000 |
| Sep 2025 | 274,114,000 | 151,579,000 | 79,670,000 | 42,211,000 | 3,442,280,000 | 119,106,000 | 1,617,311,000 |
| Jun 2025 | 249,530,000 | 140,331,000 | 71,756,000 | 47,466,000 | 3,431,625,000 | 139,502,000 | 1,576,143,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$257,627,000
Investing CF
$-136,841,000
Financing CF
$-156,062,000
CapEx
$-11,178,000
Dividends Paid
—
Buybacks
$-156,283,000
EPS Diluted TTM
$4.00
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$1,746,103,000
Inventory
$159,132,000
Receivables
$191,920,000
ST Investments
—
EBIT TTM
$299,835,000
Pretax Income TTM
$257,496,000
Interest Exp TTM
$42,339,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,088,705,024
EBITDA
$340,681,984
Free Cash Flow
$192,759,744
Enterprise Value
$3,192,419,072
Total Cash
$63,868,000
Total Debt
$1,045,427,968
Shares Out
47,372,166
Trailing EPS
$3.91
Book Value
$39.89
ROE
10.2%
ROA
5.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,088,705,000 | 309,409,000 | 190,301,000 | 3,494,313,000 | 1,606,797,000 | — | 257,627,000 |
| Mar 2025 | 1,137,762,000 | 349,241,000 | 214,605,000 | 3,402,218,000 | 1,567,321,000 | — | 251,515,000 |
| Mar 2024 | 1,125,357,000 | 342,429,000 | 209,339,000 | 3,318,417,000 | 1,663,333,000 | — | 248,926,000 |
| Mar 2023 | 1,127,725,000 | 347,802,000 | -82,306,000 | 3,353,729,000 | 1,906,645,000 | — | 229,716,000 |
TTM Snapshot
Revenues TTM
$1,123,052,000
NetIncome TTM
$216,244,000
OpCashFlow TTM
$0
Assets (Latest)
$3,402,218,000
Forward EPS
$5.02
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $45.00 · spot: $47.24 · call volume: 31 · put volume: 38Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PHVS | Pharvaris N.V. | $2.20B | $31.54 | — |
| GIFOF | Grifols SA | $2.29B | $8.85 | — |
| MLYS | Mineralys Therapeutics, Inc. | $2.11B | $23.92 | — |
| TRVI | Trevi Therapeutics, Inc. | $2.08B | $14.66 | — |
| NKTR | NEKTAR THERAPEUTICS | $2.07B | $61.15 | — |
News headlines (Yahoo Finance, 1h cache)
Prestige Consumer Healthcare Inc Completes Acquisition of Breathe Right®
2026-06-15 13:00 · Yahoo
Does Earnings Miss, Weaker Outlook and Probe Into Disclosures Change The Bull Case For PBH?
2026-06-14 04:14 · Yahoo
Why Is Prestige Consumer Healthcare (PBH) Up 3.6% Since Last Earnings Report?
2026-06-12 15:30 · Yahoo
Prestige Consumer Healthcare Inc. to Participate in the Oppenheimer Annual Consumer Growth and E-Commerce Conference
2026-06-05 12:44 · Yahoo
Why Canaccord Reduced Prestige Consumer Healthcare Inc. (PBH) Price Target After Q4 Weakness
2026-06-02 14:10 · Yahoo
Is the Options Market Predicting a Spike in Prestige Consumer Stock?
2026-06-01 19:16 · Yahoo
Prestige Consumer Healthcare Inc. Just Missed Earnings - But Analysts Have Updated Their Models
2026-05-15 12:50 · Yahoo
Prestige Consumer Healthcare Q4 Earnings Call Highlights
2026-05-15 07:07 · Yahoo
Prestige Consumer Healthcare Inc (PBH) Q4 2026 Earnings Call Highlights: Navigating Challenges ...
2026-05-14 23:02 · Yahoo
Sector Update: Healthcare Stocks Mixed Late Afternoon
2026-05-14 19:48 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.